首页 | 本学科首页   官方微博 | 高级检索  
检索        

EphA2与肿瘤
引用本文:蒋莎莉,罗招阳.EphA2与肿瘤[J].国际病理科学与临床杂志,2008,28(5):10-415.
作者姓名:蒋莎莉  罗招阳
作者单位:郴州市第一人民医院病理科,湖南,郴州,423000;南华大学肿瘤研究所,湖南,衡阳,421001
摘    要:酪氨酸蛋白激酶受体(receptor tyrosine kinases,RTKs)参与细胞增生和分化、胚胎发育和细胞内信号转导等过程,具有重要的生理功能。生促红素人肝细胞(erythropoietin-producing human hepatocelluar, Eph) A2 是Eph受体酪氨酸蛋白激酶家族RTKs中的一员,广泛表达在人类多种组织或细胞系中,对调节细胞生长、迁移及血管形成有潜在的作用。EphA2过表达可导致细胞的恶性转化,增强肿瘤细胞的侵袭性和转移性。EphA2有望成为恶性肿瘤治疗的新的靶点和预后指标。

关 键 词:生促红素人肝细胞A2  酪氨酸蛋白激酶受体  肿瘤
收稿时间:2008-5-10
修稿时间:2008-6-1

EphA2 and tumor
JIANG Sha-li,LUO Zhao-yang.EphA2 and tumor[J].Journal of International Pathology and Clinical Medicine,2008,28(5):10-415.
Authors:JIANG Sha-li  LUO Zhao-yang
Institution:1. Department of Pathology, Chenzhou First People’s Hospital,Chenzhou Hunan 423000;
2. Institute of Cancer Research, Nanhua University, Hengyang Hunan 421001, China
Abstract:Receptor tyrosine kinases(RTKs) are involved in cellular growth,differentiation,embryonic development,and intracellular signalling pathways,and possess important physiological functions.EphA2 belongs to Eph receptor tyrosine kinase family(RTKs),widely expressed in human tissues and plays a role in regulating cell growth,migration and angiogenesis.Recent studies have shown that its over-expression can lead to the cell's malignant transformation and enhance the invasive of tumor cells.Therefore,EphA2 may become a malignant tumor prognostic indicator,and a new cancer therapy target.
Keywords:EphA2  receptor tyrosine kinases(RTKs)  neoplasm
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《国际病理科学与临床杂志》浏览原始摘要信息
点击此处可从《国际病理科学与临床杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号